Annual Operating Profit
-$13.58 M
+$7.68 M+36.13%
31 December 2023
Summary:
GT Biopharma annual operaing income is currently -$13.58 million, with the most recent change of +$7.68 million (+36.13%) on 31 December 2023. During the last 3 years, it has fallen by -$6.81 million (-100.71%). GTBP annual operating profit is now -2815.20% below its all-time high of $500.00 thousand, reached on 31 December 1989.GTBP Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$3.60 M
+$302.00 K+7.73%
30 September 2024
Summary:
GT Biopharma quarterly operating income is currently -$3.60 million, with the most recent change of +$302.00 thousand (+7.73%) on 30 September 2024. Over the past year, it has dropped by -$482.00 thousand (-15.44%). GTBP quarterly operating profit is now -312.00% below its all-time high of $1.70 million, reached on 30 June 1989.GTBP Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$13.77 M
-$482.00 K-3.63%
30 September 2024
Summary:
GT Biopharma TTM operating income is currently -$13.77 million, with the most recent change of -$482.00 thousand (-3.63%) on 30 September 2024. Over the past year, it has increased by +$2.42 million (+14.93%). GTBP TTM operating profit is now -482.47% below its all-time high of $3.60 million, reached on 01 September 1984.GTBP TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.1% | -15.4% | +14.9% |
| 3 y3 years | -100.7% | +39.5% | +66.8% |
| 5 y5 years | +37.0% | +15.3% | -0.6% |
GTBP Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.7% | +76.4% | -19.6% | +80.2% | -5.9% | +76.1% |
| 5 y | 5 years | -100.7% | +76.4% | -316.2% | +87.6% | -153.2% | +76.1% |
| alltime | all time | -2815.2% | +90.0% | -312.0% | +97.2% | -482.5% | +90.5% |
GT Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.60 M(-7.7%) | -$13.77 M(+3.6%) |
| June 2024 | - | -$3.91 M(+26.4%) | -$13.29 M(+2.2%) |
| Mar 2024 | - | -$3.09 M(-2.4%) | -$13.00 M(-4.2%) |
| Dec 2023 | -$13.58 M(-36.1%) | -$3.17 M(+1.5%) | -$13.58 M(-16.1%) |
| Sept 2023 | - | -$3.12 M(-13.8%) | -$16.19 M(-19.4%) |
| June 2023 | - | -$3.62 M(-1.2%) | -$20.09 M(+3.1%) |
| Mar 2023 | - | -$3.67 M(-36.6%) | -$19.48 M(-8.4%) |
| Dec 2022 | -$21.26 M(-63.0%) | -$5.78 M(-17.7%) | -$21.26 M(-36.8%) |
| Sept 2022 | - | -$7.02 M(+133.0%) | -$33.66 M(+3.3%) |
| June 2022 | - | -$3.01 M(-44.6%) | -$32.59 M(-4.0%) |
| Mar 2022 | - | -$5.44 M(-70.1%) | -$33.95 M(-41.0%) |
| Dec 2021 | -$57.52 M(+750.3%) | -$18.18 M(+205.3%) | -$57.52 M(+38.5%) |
| Sept 2021 | - | -$5.95 M(+35.9%) | -$41.53 M(+10.7%) |
| June 2021 | - | -$4.38 M(-84.9%) | -$37.52 M(+8.1%) |
| Mar 2021 | - | -$29.00 M(+1223.7%) | -$34.70 M(+413.0%) |
| Dec 2020 | -$6.76 M(-41.0%) | -$2.19 M(+12.6%) | -$6.76 M(+24.4%) |
| Sept 2020 | - | -$1.95 M(+24.8%) | -$5.44 M(-29.8%) |
| June 2020 | - | -$1.56 M(+45.6%) | -$7.75 M(-8.5%) |
| Mar 2020 | - | -$1.07 M(+23.6%) | -$8.47 M(-26.1%) |
| Dec 2019 | -$11.46 M(-46.8%) | -$866.00 K(-79.7%) | -$11.46 M(-16.3%) |
| Sept 2019 | - | -$4.26 M(+86.7%) | -$13.68 M(-12.1%) |
| June 2019 | - | -$2.28 M(-43.8%) | -$15.57 M(-15.6%) |
| Mar 2019 | - | -$4.06 M(+31.2%) | -$18.45 M(-14.4%) |
| Dec 2018 | -$21.55 M(-84.1%) | -$3.09 M(-49.7%) | -$21.55 M(-11.5%) |
| Sept 2018 | - | -$6.15 M(+19.2%) | -$24.35 M(-83.2%) |
| June 2018 | - | -$5.16 M(-28.0%) | -$145.06 M(+2.7%) |
| Mar 2018 | - | -$7.16 M(+21.5%) | -$141.19 M(+4.1%) |
| Dec 2017 | -$135.57 M(+1346.2%) | -$5.89 M(-95.4%) | -$135.57 M(+3.9%) |
| Sept 2017 | - | -$126.86 M(+9772.1%) | -$130.50 M(+2013.4%) |
| June 2017 | - | -$1.28 M(-16.4%) | -$6.17 M(-11.9%) |
| Mar 2017 | - | -$1.54 M(+87.1%) | -$7.01 M(-25.2%) |
| Dec 2016 | -$9.37 M(+5.0%) | -$822.00 K(-67.5%) | -$9.37 M(-18.2%) |
| Sept 2016 | - | -$2.53 M(+19.3%) | -$11.46 M(-2.1%) |
| June 2016 | - | -$2.12 M(-45.6%) | -$11.71 M(+6.3%) |
| Mar 2016 | - | -$3.90 M(+34.1%) | -$11.02 M(+23.4%) |
| Dec 2015 | -$8.93 M(+272.6%) | -$2.91 M(+4.7%) | -$8.93 M(+16.5%) |
| Sept 2015 | - | -$2.78 M(+94.1%) | -$7.66 M(+41.0%) |
| June 2015 | - | -$1.43 M(-21.0%) | -$5.43 M(+32.3%) |
| Mar 2015 | - | -$1.81 M(+10.3%) | -$4.11 M(+71.4%) |
| Dec 2014 | -$2.40 M(+202.1%) | -$1.64 M(+199.1%) | -$2.40 M(+143.0%) |
| Sept 2014 | - | -$549.00 K(+427.9%) | -$986.00 K(+70.9%) |
| June 2014 | - | -$104.00 K(+3.0%) | -$577.00 K(+5.5%) |
| Mar 2014 | - | -$101.00 K(-56.5%) | -$547.00 K(-31.0%) |
| Dec 2013 | -$793.00 K(-77.4%) | -$232.00 K(+65.7%) | -$793.00 K(-39.0%) |
| Sept 2013 | - | -$140.00 K(+89.2%) | -$1.30 M(-48.2%) |
| June 2013 | - | -$74.00 K(-78.7%) | -$2.51 M(-27.6%) |
| Mar 2013 | - | -$347.00 K(-53.0%) | -$3.47 M(-1.4%) |
| Dec 2012 | -$3.51 M(-10.5%) | -$739.00 K(-45.3%) | -$3.52 M(-8.1%) |
| Sept 2012 | - | -$1.35 M(+31.1%) | -$3.83 M(+26.8%) |
| June 2012 | - | -$1.03 M(+159.4%) | -$3.02 M(+22.3%) |
| Mar 2012 | - | -$397.00 K(-62.1%) | -$2.47 M(-37.2%) |
| Dec 2011 | -$3.93 M(+57.3%) | -$1.05 M(+93.7%) | -$3.93 M(+15.3%) |
| Sept 2011 | - | -$541.00 K(+12.5%) | -$3.41 M(-3.2%) |
| June 2011 | - | -$481.00 K(-74.1%) | -$3.52 M(+2.8%) |
| Mar 2011 | - | -$1.86 M(+252.6%) | -$3.42 M(+37.2%) |
| Dec 2010 | -$2.50 M(+116.0%) | -$527.00 K(-19.4%) | -$2.50 M(-7.0%) |
| Sept 2010 | - | -$654.00 K(+69.4%) | -$2.68 M(+26.8%) |
| June 2010 | - | -$386.00 K(-58.5%) | -$2.12 M(+8.7%) |
| Mar 2010 | - | -$930.00 K(+30.3%) | -$1.95 M(+68.4%) |
| Dec 2009 | -$1.16 M(-4.5%) | -$714.00 K(+720.7%) | -$1.16 M(+68.5%) |
| Sept 2009 | - | -$87.00 K(-59.7%) | -$686.00 K(-33.1%) |
| June 2009 | - | -$216.00 K(+55.4%) | -$1.02 M(+21.0%) |
| Mar 2009 | - | -$139.00 K(-43.0%) | -$847.00 K(-30.1%) |
| Dec 2008 | -$1.21 M(+8.5%) | -$244.00 K(-42.7%) | -$1.21 M(-32.9%) |
| Sept 2008 | - | -$426.00 K(+1021.1%) | -$1.81 M(+12.2%) |
| June 2008 | - | -$38.00 K(-92.4%) | -$1.61 M(+38.0%) |
| Mar 2008 | - | -$503.00 K(-40.0%) | -$1.17 M(+4.6%) |
| Dec 2007 | -$1.12 M(-58.2%) | -$839.00 K(+264.8%) | -$1.12 M(-25.7%) |
| Sept 2007 | - | -$230.00 K(-156.8%) | -$1.50 M(-8.7%) |
| June 2007 | - | $405.00 K(-189.6%) | -$1.65 M(-35.3%) |
| Mar 2007 | - | -$452.00 K(-63.1%) | -$2.54 M(-4.8%) |
| Dec 2006 | -$2.67 M(+58.1%) | -$1.23 M(+228.4%) | -$2.67 M(+21.1%) |
| Sept 2006 | - | -$373.00 K(-24.2%) | -$2.20 M(+1.5%) |
| June 2006 | - | -$492.00 K(-15.2%) | -$2.17 M(+7.7%) |
| Mar 2006 | - | -$580.00 K(-23.6%) | -$2.02 M(+19.4%) |
| Dec 2005 | -$1.69 M(+46.1%) | -$759.00 K(+123.2%) | -$1.69 M(+122.8%) |
| Sept 2005 | - | -$340.00 K(+0.9%) | -$758.00 K(+176.6%) |
| June 2005 | - | -$337.00 K(+33.2%) | -$274.00 K(-37.7%) |
| Mar 2005 | - | -$253.00 K(-247.1%) | -$440.00 K(-30.3%) |
| Dec 2004 | -$1.16 M | $172.00 K(+19.4%) | -$631.00 K(-37.3%) |
| Sept 2004 | - | $144.00 K(-128.6%) | -$1.01 M(-22.0%) |
| June 2004 | - | -$503.00 K(+13.3%) | -$1.29 M(+21.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2004 | - | -$444.00 K(+117.6%) | -$1.06 M(+37.5%) |
| Dec 2003 | -$773.00 K(-4.7%) | -$204.00 K(+45.7%) | -$773.00 K(+15.4%) |
| Sept 2003 | - | -$140.00 K(-49.1%) | -$670.00 K(-18.9%) |
| June 2003 | - | -$275.00 K(+78.6%) | -$826.00 K(+16.7%) |
| Mar 2003 | - | -$154.00 K(+52.5%) | -$708.00 K(-12.7%) |
| Dec 2002 | -$811.00 K(-76.5%) | -$101.00 K(-65.9%) | -$811.00 K(-7.5%) |
| Sept 2002 | - | -$296.00 K(+88.5%) | -$877.00 K(-7.4%) |
| June 2002 | - | -$157.00 K(-38.9%) | -$947.00 K(-62.8%) |
| Mar 2002 | - | -$257.00 K(+53.9%) | -$2.54 M(-26.2%) |
| Dec 2001 | -$3.45 M(-26.9%) | -$167.00 K(-54.4%) | -$3.45 M(-27.2%) |
| Sept 2001 | - | -$366.00 K(-79.1%) | -$4.74 M(-14.3%) |
| June 2001 | - | -$1.75 M(+51.4%) | -$5.53 M(+12.4%) |
| Mar 2001 | - | -$1.16 M(-20.3%) | -$4.92 M(+4.0%) |
| Dec 2000 | -$4.73 M(+7.2%) | -$1.46 M(+25.5%) | -$4.73 M(+25.0%) |
| Sept 2000 | - | -$1.16 M(+1.4%) | -$3.78 M(+4.4%) |
| June 2000 | - | -$1.14 M(+18.0%) | -$3.62 M(-15.4%) |
| Mar 2000 | - | -$969.00 K(+90.0%) | -$4.28 M(-5.1%) |
| Dec 1999 | -$4.41 M(-37.9%) | -$510.00 K(-49.0%) | -$4.51 M(-26.1%) |
| Sept 1999 | - | -$1.00 M(-44.4%) | -$6.10 M(-16.4%) |
| June 1999 | - | -$1.80 M(+50.0%) | -$7.30 M(+9.0%) |
| Mar 1999 | - | -$1.20 M(-42.9%) | -$6.70 M(-9.5%) |
| Dec 1998 | -$7.10 M(+42.0%) | -$2.10 M(-4.5%) | -$7.40 M(+17.5%) |
| Sept 1998 | - | -$2.20 M(+83.3%) | -$6.30 M(+14.5%) |
| June 1998 | - | -$1.20 M(-36.8%) | -$5.50 M(-3.5%) |
| Mar 1998 | - | -$1.90 M(+90.0%) | -$5.70 M(+11.8%) |
| Dec 1997 | -$5.00 M(-15.3%) | -$1.00 M(-28.6%) | -$5.10 M(-10.5%) |
| Sept 1997 | - | -$1.40 M(0.0%) | -$5.70 M(-1.7%) |
| June 1997 | - | -$1.40 M(+7.7%) | -$5.80 M(-3.3%) |
| Mar 1997 | - | -$1.30 M(-18.8%) | -$6.00 M(-1.6%) |
| Dec 1996 | -$5.90 M(+7.3%) | -$1.60 M(+6.7%) | -$6.10 M(-3.2%) |
| Sept 1996 | - | -$1.50 M(-6.3%) | -$6.30 M(+1.6%) |
| June 1996 | - | -$1.60 M(+14.3%) | -$6.20 M(+3.3%) |
| Mar 1996 | - | -$1.40 M(-22.2%) | -$6.00 M(+11.1%) |
| Dec 1995 | -$5.50 M(+175.0%) | -$1.80 M(+28.6%) | -$5.40 M(+22.7%) |
| Sept 1995 | - | -$1.40 M(0.0%) | -$4.40 M(+15.8%) |
| June 1995 | - | -$1.40 M(+75.0%) | -$3.80 M(+40.7%) |
| Mar 1995 | - | -$800.00 K(0.0%) | -$2.70 M(+35.0%) |
| Dec 1994 | -$2.00 M(+17.6%) | -$800.00 K(0.0%) | -$2.00 M(+33.3%) |
| Sept 1994 | - | -$800.00 K(+166.7%) | -$1.50 M(+36.4%) |
| June 1994 | - | -$300.00 K(+200.0%) | -$1.10 M(-38.9%) |
| Mar 1994 | - | -$100.00 K(-66.7%) | -$1.80 M(0.0%) |
| Dec 1993 | -$1.70 M(+240.0%) | -$300.00 K(-25.0%) | -$1.80 M(+12.5%) |
| Sept 1993 | - | -$400.00 K(-60.0%) | -$1.60 M(+23.1%) |
| June 1993 | - | -$1.00 M(+900.0%) | -$1.30 M(+225.0%) |
| Mar 1993 | - | -$100.00 K(0.0%) | -$400.00 K(-20.0%) |
| Dec 1992 | -$500.00 K(0.0%) | -$100.00 K(0.0%) | -$500.00 K(0.0%) |
| Sept 1992 | - | -$100.00 K(0.0%) | -$500.00 K(0.0%) |
| June 1992 | - | -$100.00 K(-50.0%) | -$500.00 K(-350.0%) |
| Mar 1992 | - | -$200.00 K(+100.0%) | $200.00 K(-81.8%) |
| Dec 1991 | -$500.00 K(-200.0%) | -$100.00 K(0.0%) | $1.10 M(-168.8%) |
| Sept 1991 | - | -$100.00 K(-116.7%) | -$1.60 M(+220.0%) |
| June 1991 | - | $600.00 K(-14.3%) | -$500.00 K(-600.0%) |
| Mar 1991 | - | $700.00 K(-125.0%) | $100.00 K(-80.0%) |
| Dec 1990 | $500.00 K(0.0%) | -$2.80 M(-380.0%) | $500.00 K(+400.0%) |
| Sept 1990 | - | $1.00 M(-16.7%) | $100.00 K(>+9900.0%) |
| June 1990 | - | $1.20 M(+9.1%) | $0.00(-100.0%) |
| Mar 1990 | - | $1.10 M(-134.4%) | $500.00 K(0.0%) |
| Dec 1989 | $500.00 K(-600.0%) | -$3.20 M(-455.6%) | $500.00 K(-61.5%) |
| Sept 1989 | - | $900.00 K(-47.1%) | $1.30 M(+18.2%) |
| June 1989 | - | $1.70 M(+54.5%) | $1.10 M(+120.0%) |
| Mar 1989 | - | $1.10 M(-145.8%) | $500.00 K(-600.0%) |
| Dec 1988 | -$100.00 K(-150.0%) | -$2.40 M(-442.9%) | -$100.00 K(-116.7%) |
| Sept 1988 | - | $700.00 K(-36.4%) | $600.00 K(0.0%) |
| June 1988 | - | $1.10 M(+120.0%) | $600.00 K(+500.0%) |
| Mar 1988 | - | $500.00 K(-129.4%) | $100.00 K(-50.0%) |
| Dec 1987 | $200.00 K(-133.3%) | -$1.70 M(-342.9%) | $200.00 K(-113.3%) |
| Sept 1987 | - | $700.00 K(+16.7%) | -$1.50 M(+15.4%) |
| June 1987 | - | $600.00 K(0.0%) | -$1.30 M(+62.5%) |
| Mar 1987 | - | $600.00 K(-117.6%) | -$800.00 K(0.0%) |
| Dec 1986 | -$600.00 K(-25.0%) | -$3.40 M(-477.8%) | -$800.00 K(<-9900.0%) |
| Sept 1986 | - | $900.00 K(-18.2%) | $0.00(-100.0%) |
| June 1986 | - | $1.10 M(+83.3%) | -$500.00 K(-44.4%) |
| Mar 1986 | - | $600.00 K(-123.1%) | -$900.00 K(+12.5%) |
| Dec 1985 | -$800.00 K(-900.0%) | -$2.60 M(-750.0%) | -$800.00 K(-52.9%) |
| Sept 1985 | - | $400.00 K(-42.9%) | -$1.70 M(+88.9%) |
| June 1985 | - | $700.00 K(0.0%) | -$900.00 K(+125.0%) |
| Mar 1985 | - | $700.00 K(-120.0%) | -$400.00 K(-500.0%) |
| Dec 1984 | $100.00 K(-120.0%) | - | - |
| Dec 1984 | - | -$3.50 M(-391.7%) | $100.00 K(-97.2%) |
| Sept 1984 | - | $1.20 M(0.0%) | $3.60 M(+50.0%) |
| June 1984 | - | $1.20 M(0.0%) | $2.40 M(+100.0%) |
| Mar 1984 | - | $1.20 M | $1.20 M |
| Feb 1984 | -$500.00 K | - | - |
FAQ
- What is GT Biopharma annual operaing income?
- What is the all time high annual operating profit for GT Biopharma?
- What is GT Biopharma annual operating profit year-on-year change?
- What is GT Biopharma quarterly operating income?
- What is the all time high quarterly operating profit for GT Biopharma?
- What is GT Biopharma quarterly operating profit year-on-year change?
- What is GT Biopharma TTM operating income?
- What is the all time high TTM operating profit for GT Biopharma?
- What is GT Biopharma TTM operating profit year-on-year change?
What is GT Biopharma annual operaing income?
The current annual operating profit of GTBP is -$13.58 M
What is the all time high annual operating profit for GT Biopharma?
GT Biopharma all-time high annual operaing income is $500.00 K
What is GT Biopharma annual operating profit year-on-year change?
Over the past year, GTBP annual operaing income has changed by +$7.68 M (+36.13%)
What is GT Biopharma quarterly operating income?
The current quarterly operating profit of GTBP is -$3.60 M
What is the all time high quarterly operating profit for GT Biopharma?
GT Biopharma all-time high quarterly operating income is $1.70 M
What is GT Biopharma quarterly operating profit year-on-year change?
Over the past year, GTBP quarterly operating income has changed by -$482.00 K (-15.44%)
What is GT Biopharma TTM operating income?
The current TTM operating profit of GTBP is -$13.77 M
What is the all time high TTM operating profit for GT Biopharma?
GT Biopharma all-time high TTM operating income is $3.60 M
What is GT Biopharma TTM operating profit year-on-year change?
Over the past year, GTBP TTM operating income has changed by +$2.42 M (+14.93%)